Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Yiqi Yangyin Formula is a Traditional Chinese Medicine (TCM) herbal preparation specifically utilized for the treatment of **Primary Sjögren's Syndrome (pSS)**. Based on the TCM therapeutic principle of "supplementing Qi and nourishing Yin," the formula is designed to address the underlying "Qi and Yin deficiency" that characterizes the clinical presentation of dryness (xerostomia and keratoconjunctivitis sicca) and systemic fatigue. While the specific composition can vary between institutions, the formula used in clinical research (such as those led by **Guang'anmen Hospital**) typically includes herbs like *Radix Astragali* (Huangqi), *Radix Rehmanniae* (Shengdi), and *Radix Ophiopogonis* (Maidong). Mechanistically, it is thought to modulate the immune system by reducing the production of pro-inflammatory cytokines, regulating B-cell activity, and potentially protecting the secretory function of the salivary and lacrimal glands.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Yiqi Yangyin Formula.